Bayer Floats $2B Deal in Attempt to Head Off Future Roundup Cancer Claims

Monsanto owner Bayer AG hopes the federal judge who rejected the pesticide maker’s prior plan will approve the new deal, which includes at least $1.325 billion to compensate future “qualified” claimants.